Researchers at Fuji Chemical Industry (Fuji; Toyama, Japan) are researching the supplement AstaREAL astaxanthin for its potential to cure asthenopia, commonly known as eye fatigue, reports its U.S. subsidiary Fuji Health Science (Burlington, NJ).
Researchers at Fuji Chemical Industry (Fuji; Toyama, Japan) are researching the supplement AstaREAL astaxanthin for its potential to cure asthenopia, commonly known as eye fatigue, reports its U.S. subsidiary Fuji Health Science (Burlington, NJ).
Astaxanthin is a natural antioxidant that can be abundantly found in the freshwater microalgae, Haematococcus pluvialis. Fuji scientists believe it can reduce cellular inflammation and improve capillary blood flow for the lens of the eye. The company has sponsored eleven human studies with astaxanthin on patients with symptoms of asthenopia. Fuji also cultivates astaxanthin at locations in Hawaii and Sweden.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.